Computational Repurposing Screen of FDA-Approved Anti-Inflammatory and Antiviral Drugs Against BACE1 (β-Secretase 1): A Blind Molecular Docking Study
Sanav Kumar
This study screened 36 FDA-approved anti-inflammatory and antiviral compounds against human BACE1 using blind molecular docking, nominating HIV-1 protease inhibitors as a testable hypothesis for Alzheimer's drug repurposing.